WO2009057569A1 - Film-coated preparation - Google Patents

Film-coated preparation Download PDF

Info

Publication number
WO2009057569A1
WO2009057569A1 PCT/JP2008/069487 JP2008069487W WO2009057569A1 WO 2009057569 A1 WO2009057569 A1 WO 2009057569A1 JP 2008069487 W JP2008069487 W JP 2008069487W WO 2009057569 A1 WO2009057569 A1 WO 2009057569A1
Authority
WO
WIPO (PCT)
Prior art keywords
film
coated preparation
disclosed
coated
preparation
Prior art date
Application number
PCT/JP2008/069487
Other languages
French (fr)
Japanese (ja)
Inventor
Takeshi Hamaura
Susumu Hasegawa
Ikumasa Ohno
Original Assignee
Daiichi Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited
Priority to JP2009539054A priority Critical patent/JPWO2009057569A1/en
Priority to CN200880114044A priority patent/CN101842096A/en
Publication of WO2009057569A1 publication Critical patent/WO2009057569A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed is a film-coated preparation, in which the odor of a medicinal agent contained therein can be reduced. Specifically disclosed is a film-coated preparation which contains olmesartan medoxomil in its formulation, and which contains polyvinyl alcohol or a vinyl alcohol-containing copolymer in its film layer.
PCT/JP2008/069487 2007-10-29 2008-10-28 Film-coated preparation WO2009057569A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009539054A JPWO2009057569A1 (en) 2007-10-29 2008-10-28 Film coating formulation
CN200880114044A CN101842096A (en) 2007-10-29 2008-10-28 Film-coated preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007280843 2007-10-29
JP2007-280843 2007-10-29

Publications (1)

Publication Number Publication Date
WO2009057569A1 true WO2009057569A1 (en) 2009-05-07

Family

ID=40590960

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069487 WO2009057569A1 (en) 2007-10-29 2008-10-28 Film-coated preparation

Country Status (5)

Country Link
JP (1) JPWO2009057569A1 (en)
KR (1) KR20100072317A (en)
CN (1) CN101842096A (en)
TW (1) TW200927197A (en)
WO (1) WO2009057569A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011025035A1 (en) * 2009-08-31 2011-03-03 日新化成株式会社 Coating composition
JP2012193175A (en) * 2011-03-02 2012-10-11 Daiichi Sankyo Healthcare Co Ltd Rapidly soluble moisture-proof film-coated preparation and method for producing the same
EP2594277A1 (en) * 2010-07-07 2013-05-22 Japan Tobacco, Inc. Tablet containing ferric citrate
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition
WO2014188728A1 (en) * 2013-05-24 2014-11-27 持田製薬株式会社 Film-coating composition
EP2830618A4 (en) * 2012-03-30 2015-08-05 Dae Woong Pharma Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
JP2016141630A (en) * 2015-01-30 2016-08-08 富士フイルム株式会社 Orally disintegrating tablets
JP2017001999A (en) * 2015-06-12 2017-01-05 富士フイルム株式会社 Manufacturing method of medicine-containing particles, medicine-containing particles, pharmaceutical composition, and orally disintegrating tablet
WO2017164208A1 (en) * 2016-03-24 2017-09-28 第一三共株式会社 Medicine for treating renal disease

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716100B (en) * 2012-07-12 2013-08-07 南京正大天晴制药有限公司 Tablets comprising olmesartan medoxomil and method for preparing same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002179741A (en) * 2000-10-04 2002-06-26 Basf Ag Water-soluble or water-dispersible (co)polymer of hydroxyalkyl (meth)acrylate, method of producing the same, and use of the same as coating agent, binder and/or film-forming excipient in pharmaceutical dosage form
WO2005019286A1 (en) * 2003-08-20 2005-03-03 Shionogi & Co., Ltd. Novel coating composition
WO2006123765A1 (en) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited Film coated preparation
WO2006123766A1 (en) * 2005-05-20 2006-11-23 Daichi Sankyo Company, Limited Film coated preparation containing dextrose
JP2007091620A (en) * 2005-09-28 2007-04-12 Kyoto Pharmaceutical Industries Ltd Film-coated tablet
JP2007197410A (en) * 2006-01-30 2007-08-09 Lion Corp Film-coated tablet

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002179741A (en) * 2000-10-04 2002-06-26 Basf Ag Water-soluble or water-dispersible (co)polymer of hydroxyalkyl (meth)acrylate, method of producing the same, and use of the same as coating agent, binder and/or film-forming excipient in pharmaceutical dosage form
WO2005019286A1 (en) * 2003-08-20 2005-03-03 Shionogi & Co., Ltd. Novel coating composition
WO2006123765A1 (en) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited Film coated preparation
WO2006123766A1 (en) * 2005-05-20 2006-11-23 Daichi Sankyo Company, Limited Film coated preparation containing dextrose
JP2007091620A (en) * 2005-09-28 2007-04-12 Kyoto Pharmaceutical Industries Ltd Film-coated tablet
JP2007197410A (en) * 2006-01-30 2007-08-09 Lion Corp Film-coated tablet

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011025035A1 (en) * 2009-08-31 2011-03-03 日新化成株式会社 Coating composition
JP5730205B2 (en) * 2009-08-31 2015-06-03 日新化成株式会社 Coating composition
EP2594277A1 (en) * 2010-07-07 2013-05-22 Japan Tobacco, Inc. Tablet containing ferric citrate
EP2594277A4 (en) * 2010-07-07 2014-01-01 Japan Tobacco Inc Tablet containing ferric citrate
JP2012193175A (en) * 2011-03-02 2012-10-11 Daiichi Sankyo Healthcare Co Ltd Rapidly soluble moisture-proof film-coated preparation and method for producing the same
EP2830618A4 (en) * 2012-03-30 2015-08-05 Dae Woong Pharma Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition
WO2014188728A1 (en) * 2013-05-24 2014-11-27 持田製薬株式会社 Film-coating composition
JPWO2014188728A1 (en) * 2013-05-24 2017-02-23 持田製薬株式会社 Film coating composition
JP2016141630A (en) * 2015-01-30 2016-08-08 富士フイルム株式会社 Orally disintegrating tablets
JP2017001999A (en) * 2015-06-12 2017-01-05 富士フイルム株式会社 Manufacturing method of medicine-containing particles, medicine-containing particles, pharmaceutical composition, and orally disintegrating tablet
WO2017164208A1 (en) * 2016-03-24 2017-09-28 第一三共株式会社 Medicine for treating renal disease

Also Published As

Publication number Publication date
CN101842096A (en) 2010-09-22
JPWO2009057569A1 (en) 2011-03-10
KR20100072317A (en) 2010-06-30
TW200927197A (en) 2009-07-01

Similar Documents

Publication Publication Date Title
WO2009057569A1 (en) Film-coated preparation
WO2007073520A3 (en) Polymer interlayers comprising ethylene-vinyl acetate copolymer
WO2008100375A3 (en) Polymer-based films and drug delivery systems made therefrom
WO2010022154A3 (en) Release materials
WO2008067387A3 (en) Estrogen/ serm and estrogen/ progestin bi-layer tablets
MX2009010690A (en) Method and composition for zonal isolation of a well.
WO2011084593A3 (en) Abuse-resistant formulations
WO2010037728A3 (en) Formulations comprising ezetimibe
EP2319884A4 (en) Ethylene-vinyl acetate copolymer composition, ethylene-vinyl acetate copolymer film and method for producing same
EP2194104A4 (en) Composition for formation of hydrophilic film, and hydrophilic member
CR20110072A (en) DRUG ADMINISTRATION SYSTEM CONTAINING PROGESTINE
WO2011031558A3 (en) Toughened polyhydroxyalkanoate compositions
WO2007109057A3 (en) Solid dosage form containing a taste masked active agent
WO2010026433A3 (en) Polymeric material
WO2009129301A3 (en) Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
WO2010055119A3 (en) Pharmaceutical composition comprising pimobendan
EP2030992A4 (en) Method for producing unsaturated carboxylic acid-modified vinyl alcohol polymer, and gas barrier film or gas barrier laminate using the same
MX2009005445A (en) Delivery system for risperidone.
EP2221321A4 (en) Vinyl alcohol system polymer and film containing same
WO2007080509A3 (en) Sustained release compositions of alfuzosin
PL2197436T3 (en) Sucking tablet for use in reducing tobacco and/or alcohol dependence
EP1785446A4 (en) Multilayered pellet comprising ethylene/vinyl alcohol copolymer resin compositions
WO2007064560A3 (en) Barrier panel
EP2178688A4 (en) Cross directional zoned bicomponent films, film laminates, and systems and method for manufacture of the same
WO2009149058A3 (en) Modified release niacin formulations

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880114044.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845153

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009539054

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 20107009312

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08845153

Country of ref document: EP

Kind code of ref document: A1